EmailHospital Circular 22/2007
Date issued: 25 October 2007
Distribution: Public hospitals
Subject: Highly Specialised Drugs Program
Purpose: To advise hospitals of changes to the Highly Specialised Drugs Program, effective 1 November 2007
We have had recent advice from the Commonwealth Government of changes to the Highly Specialised Drugs Program, effective 1 November 2007.
ADDED ITEMS:
| Etanercept | |||||
| 9615C | Injections 50mg in 1ml single use pre-filled syringes, 4 pack | 1 | Enbrel | $1630.01 | WX |
Atazanavir |
|||||
| 9614B | Capsule 300mg (as sulfate) | 30 | Reyataz | $521.91 | BQ |
Full prescribing criteria for all items available at the Commonwealth/State Highly Specialised Drugs Program Guidelines website.
Changes notified by hospital circular will be updated in the Guidelines on the Commonwealth/State Highly Specialised Drugs Program Guidelines website and the claim form amended.
Approved by
Dr Jennifer King
Director, Programs
Metropolitan Health & Aged Care Services
